These studies have played a crucial role in understanding the antigenic targets of CD4+ T cells in T1D, which has not only provided novel insights into disease pathogenesis but may also be useful for testing antigen specific therapies for disease prevention (108). The gene discussed is CD4; the disease is type 1 diabetes mellitus.